Trinity Biotech PLC (TRIB) stock
TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$6.10+0.22 (+3.74%)
Close on Nov 13, 2026Market cap $114.13MP/E –Yield –
Trinity Biotech profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2025 it was -85.4%, against -51.6% the year before. The highest annual figure on record is 21.8% in fiscal 2015.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -85.4% | −33.7 |
| FY2024 | Dec 31, 2024 | -51.6% | −9.4 |
| FY2023 | Dec 31, 2023 | -42.3% | +23.3 |
| FY2022 | Dec 31, 2022 | -65.6% | −66.7 |
| FY2021 | Dec 31, 2021 | 1.1% | +7.3 |
| FY2020 | Dec 31, 2020 | -6.3% | +25.7 |
| FY2019 | Dec 31, 2019 | -32.0% | −9.2 |
| FY2018 | Dec 31, 2018 | -22.8% | +17.9 |
| FY2017 | Dec 31, 2017 | -40.6% | +60.4 |
| FY2016 | Dec 31, 2016 | -101.0% | −122.8 |
| FY2015 | Dec 31, 2015 | 21.8% | – |
See a number that looks wrong?